美國居民不適用 XM 服務。

Medical gear maker Getinge beats profit expectations, shares jump



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 3-Medical gear maker Getinge beats profit expectations, shares jump</title></head><body>

Updates share reaction in paragraph 2, adds CEO, CFO comments in paragraphs 5, 9, 11

By Greta Rosen Fondahn and Elsa Ohlen

April 22 (Reuters) -Medical equipment maker Getinge GETIb.ST reported a smaller than expected drop in first-quarter core profit on Monday, as new orders offset the costs of resolving prolonged problems with its product packaging and heart products.

The news sent the shares up 6% in afternoon trade in Stockholm, outperforming the wider index .OMXS30 and on track for their biggest intra-session jump in more than a year.

Its quarterly earnings before interest, tax and amortisation (EBITA), adjusted for items affecting comparability, fell 13.4% from a year earlier to 842 million Swedish crowns ($77 million), but exceeded a consensus of 770 million cited by J.P.Morgan.

Getinge has struggled to resolve quality problems with sterile packaging of products for heart-lung support systems and with its heart pumps that have squeezed its margins and knocked its shares since the second quarter last year.

The work to resolve those challenges will continue to affect Getinge this year, though it has made some progress on the packaging issue, CEO Mattias Perjos told Reuters.

The company said it had submitted a CE certificate application at the end of the first quarter for a new kind of packaging for a heart-lung therapy product. It also expects to submit an application for a second product soon, without giving specific timing.

"I am convinced that we have thus come much closer to a final solution to these challenges," Perjos said in a statement.

Work to improve quality in its Acute Care Therapies unit, which makes heart and intensive care products, cost Getinge around 800 million crowns last year.

Costs for quality improvements in 2024 are expected to be roughly half of those incurred last year, CFO Agneta Palmer said in a call with analysts.

Getinge's orders grew by 2.5% organically in the first three months of 2024, after falling for three consecutive quarters.

The underlying market is positive for Getinge, with investments in hospital equipment on the rise globally, Perjos said. That should have a positive impact on orders, although China remains a drag, he added.

($1 = 10.9025 Swedish crowns)



Reporting by Greta Rosen Fondahn and Elsa Ohlen in Gdansk; Editing by Milla Nissi, Barbara Lewis and Emelia Sithole-Matarise

</body></html>

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明